Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary

Rakendra Singh1, Sanjeev Kumar Singla2, Ankush Singla2

  • 1Department of Medicine, Adesh Institute of Medical Sciences and Research Bhatinda, Punjab, India.

Insights

Catheter-directed intracoronary thrombolysis (ICT) effectively reduces thrombus burden in ST-elevation myocardial infarction (STEMI) patients experiencing no-reflow. This life-saving treatment improves myocardial reperfusion with minimal side effects.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Intracoronary thrombus is a frequent complication in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).
  • Large thrombus burden can lead to embolization and a no-reflow state, increasing infarct size and mortality.
  • Catheter-directed intracoronary thrombolysis (ICT) is emerging as a strategy for managing no-reflow due to significant thrombus.

Purpose of the Study:

  • To evaluate the efficacy and safety of catheter-directed ICT in STEMI patients with no-reflow.
  • To assess the impact of ICT on thrombus burden and myocardial reperfusion.

Main Methods:

  • Retrospective observational study of 1020 adult patients.
  • Focus on 10% of patients with acute STEMI undergoing PCI with no-reflow.
  • ICT administered using low-dose tenecteplase (15 ± 5 mg).

Main Results:

  • Thrombolysis in Myocardial Infarction (TIMI) flow Grade 5 in 79.17% and Grade 4 in 20.83% prior to ICT.
  • TIMI flow Grade III achieved in 91.67% and Grade II in 8.33% post-ICT.
  • Major risk factor: tobacco smoking (41.67%). Major complication: left ventricular failure (33.33%).

Conclusions:

  • Catheter-directed ICT is a safe and effective treatment for reducing thrombus burden in STEMI.
  • ICT improves myocardial reperfusion and can be life-saving in no-reflow states.
  • This intervention offers a valuable option with minimal systemic side effects for managing complex STEMI cases.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
21
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
17
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
13
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
49
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
99